Research Article
The Serum Expression of Selected miRNAs in Pulmonary Sarcoidosis with/without Löfgren’s Syndrome
Table 2
Bronchoalveolar cellular profile in our patients with pulmonary sarcoidosis.
| Sarcoidosis | With LS (CXR 1) | Without LS (CXR 3) |
| Cellular profile | Mean (min–max) | Mean (min–max) | Total cell count 106/mL | 0.85 (0.40–1.35) | 0.72 (0.10–1.40) | Macrophage absolute count | 0.66 (0.28–1.02) | 0.58 (0.09–1.40) | Macrophage relative count (%) | 77.31 (57.00–91.10) | 76.67 (43.00–90.70) | Lymphocytes absolute count | 0.18 (0.06–0.45) | 0.14 (0.01–0.33) | Lymphocytes relative count (%) | 20.58 (8.60–41.00) | 20.08 (8.00–46.00) | Neutrophils absolute count | 0.01 (0.00–0.04) | 0.02 (0.00–0.05) | Neutrophils relative count (%) | 1.68 (0.00–8.00) | 2.27 (0.00–6.00) | Eosinophils absolute count | 0.00 (0.00–0.01) | 0.00 (0.00–0.02) | Eosinophils relative count (%) | 0.43 (0.00–2.00) | 0.99 (0.00–7.00) | CD3+ absolute count | 0.56 (0.00–1.13) | 0.35 (0.00–1.06) | CD3+ relative count (%) | 84.62 (58.00–94.00) | 75.00 (36.00–96.00) | CD4+ absolute count | 0.26 (0.00–0.79) | 0.15 (0.00–0.67) | CD4+ relative count (%) | 71.69 (35.00–90.00) | 55.58 (29.00–89.00) | CD8+ absolute count | 0.06 (0.00–0.26) | 0.04 (0.00–0.19) | CD8+ relative count (%) | 13.08 (3.00–31.00) | 21.00 (4.00–53.00) | CD19+ absolute count | 0.00 (0.00–0.01) | 0.00 (0.00–0.02) | CD19+ relative count (%) | 0.54 (0.00–2.00) | 1.08 (0.00–2.00) | CD4+/CD8+ | 9.45 (1.13–30.00) | 5.34 (0.55–22.25) |
|
|
CXR, chest X-ray; LS, Löfgren’s syndrome.
|